Matches in SemOpenAlex for { <https://semopenalex.org/work/W3107781784> ?p ?o ?g. }
- W3107781784 endingPage "1131" @default.
- W3107781784 startingPage "1131" @default.
- W3107781784 abstract "Tofacitinib (TFB), a Janus kinase inhibitor, has shown excellent success off-label in treating various dermatological diseases, especially alopecia areata (AA). However, TFB’s safe and targeted delivery into hair follicles (HFs) is highly desirable due to its systemic adverse effects. Nanoparticles (NPs) can enhance targeted follicular drug delivery and minimize interfollicular permeation and thereby reduce systemic drug exposure. In this study, we report a facile method to assemble the stable and uniform 240 nm TFB loaded squalenyl derivative (SqD) nanoparticles (TFB SqD NPs) in aqueous solution, which allowed an excellent loading capacity (LC) of 20%. The SqD NPs showed an enhanced TFB delivery into HFs compared to the aqueous formulations of plain drug in an ex vivo pig ear model. Furthermore, the therapeutic efficacy of the TFB SqD NPs was studied in a mouse model of allergic dermatitis by ear swelling reduction and compared to TFB dissolved in a non-aqueous mixture of acetone and DMSO (7:1 v/v). Whereas such formulation would not be acceptable for use in the clinic, the TFB SqD NPs dispersed in water illustrated a better reduction in inflammatory effects than plain TFB’s aqueous formulation, implying both encouraging good in vivo efficacy and safety. These findings support the potential of TFB SqD NPs for developing a long-term topical therapy of AA." @default.
- W3107781784 created "2020-12-07" @default.
- W3107781784 creator A5001597366 @default.
- W3107781784 creator A5001852425 @default.
- W3107781784 creator A5018546214 @default.
- W3107781784 creator A5025552969 @default.
- W3107781784 creator A5030937637 @default.
- W3107781784 creator A5033750684 @default.
- W3107781784 creator A5033924492 @default.
- W3107781784 creator A5041507289 @default.
- W3107781784 creator A5083523838 @default.
- W3107781784 creator A5084483753 @default.
- W3107781784 date "2020-11-24" @default.
- W3107781784 modified "2023-10-16" @default.
- W3107781784 title "Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases" @default.
- W3107781784 cites W1491373961 @default.
- W3107781784 cites W1535954439 @default.
- W3107781784 cites W1757969736 @default.
- W3107781784 cites W1916572050 @default.
- W3107781784 cites W1964501217 @default.
- W3107781784 cites W1968911993 @default.
- W3107781784 cites W1972061986 @default.
- W3107781784 cites W1974080412 @default.
- W3107781784 cites W1980860884 @default.
- W3107781784 cites W1984957474 @default.
- W3107781784 cites W1987280378 @default.
- W3107781784 cites W2005634676 @default.
- W3107781784 cites W2005732528 @default.
- W3107781784 cites W2007591700 @default.
- W3107781784 cites W2009284487 @default.
- W3107781784 cites W2022244556 @default.
- W3107781784 cites W2023283179 @default.
- W3107781784 cites W2027060246 @default.
- W3107781784 cites W2042323290 @default.
- W3107781784 cites W2044535212 @default.
- W3107781784 cites W2047581550 @default.
- W3107781784 cites W2049804077 @default.
- W3107781784 cites W2056912883 @default.
- W3107781784 cites W2075151979 @default.
- W3107781784 cites W2075203777 @default.
- W3107781784 cites W2076896224 @default.
- W3107781784 cites W2088107579 @default.
- W3107781784 cites W2120094040 @default.
- W3107781784 cites W2138729969 @default.
- W3107781784 cites W2177414249 @default.
- W3107781784 cites W2199766511 @default.
- W3107781784 cites W2414781026 @default.
- W3107781784 cites W2420387358 @default.
- W3107781784 cites W2519456377 @default.
- W3107781784 cites W2547550121 @default.
- W3107781784 cites W2566666513 @default.
- W3107781784 cites W2584816673 @default.
- W3107781784 cites W2606362171 @default.
- W3107781784 cites W2612141088 @default.
- W3107781784 cites W2765380758 @default.
- W3107781784 cites W2767394258 @default.
- W3107781784 cites W2773006631 @default.
- W3107781784 cites W2773759136 @default.
- W3107781784 cites W2780722038 @default.
- W3107781784 cites W2810273658 @default.
- W3107781784 cites W2892600061 @default.
- W3107781784 cites W2912961096 @default.
- W3107781784 cites W2921406196 @default.
- W3107781784 cites W2940248033 @default.
- W3107781784 cites W2955984083 @default.
- W3107781784 cites W2971410519 @default.
- W3107781784 cites W2977918824 @default.
- W3107781784 cites W2995577989 @default.
- W3107781784 cites W3005269120 @default.
- W3107781784 cites W3009973476 @default.
- W3107781784 cites W3014633359 @default.
- W3107781784 cites W3043372169 @default.
- W3107781784 cites W3086885776 @default.
- W3107781784 cites W3093129462 @default.
- W3107781784 cites W4211012025 @default.
- W3107781784 cites W4231446881 @default.
- W3107781784 doi "https://doi.org/10.3390/pharmaceutics12121131" @default.
- W3107781784 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7760822" @default.
- W3107781784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33255225" @default.
- W3107781784 hasPublicationYear "2020" @default.
- W3107781784 type Work @default.
- W3107781784 sameAs 3107781784 @default.
- W3107781784 citedByCount "10" @default.
- W3107781784 countsByYear W31077817842020 @default.
- W3107781784 countsByYear W31077817842021 @default.
- W3107781784 countsByYear W31077817842022 @default.
- W3107781784 countsByYear W31077817842023 @default.
- W3107781784 crossrefType "journal-article" @default.
- W3107781784 hasAuthorship W3107781784A5001597366 @default.
- W3107781784 hasAuthorship W3107781784A5001852425 @default.
- W3107781784 hasAuthorship W3107781784A5018546214 @default.
- W3107781784 hasAuthorship W3107781784A5025552969 @default.
- W3107781784 hasAuthorship W3107781784A5030937637 @default.
- W3107781784 hasAuthorship W3107781784A5033750684 @default.
- W3107781784 hasAuthorship W3107781784A5033924492 @default.
- W3107781784 hasAuthorship W3107781784A5041507289 @default.
- W3107781784 hasAuthorship W3107781784A5083523838 @default.
- W3107781784 hasAuthorship W3107781784A5084483753 @default.